142 related articles for article (PubMed ID: 7662974)
1. Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase.
Lucas JJ; Szepesi A; Domenico J; Takase K; Tordai A; Terada N; Gelfand EW
Blood; 1995 Sep; 86(6):2268-80. PubMed ID: 7662974
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
Morice WG; Wiederrecht G; Brunn GJ; Siekierka JJ; Abraham RT
J Biol Chem; 1993 Oct; 268(30):22737-45. PubMed ID: 8226784
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration.
Loyer P; Glaise D; Cariou S; Baffet G; Meijer L; Guguen-Guillouzo C
J Biol Chem; 1994 Jan; 269(4):2491-500. PubMed ID: 8300575
[TBL] [Abstract][Full Text] [Related]
6. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
Tsai LH; Lees E; Faha B; Harlow E; Riabowol K
Oncogene; 1993 Jun; 8(6):1593-602. PubMed ID: 8502482
[TBL] [Abstract][Full Text] [Related]
7. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
Tsai LH; Harlow E; Meyerson M
Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
[TBL] [Abstract][Full Text] [Related]
8. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation.
Li LJ; Naeve GS; Lee AS
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3554-8. PubMed ID: 8475104
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
Reddy KB; Hocevar BA; Howe PH
J Cell Biochem; 1994 Nov; 56(3):418-25. PubMed ID: 7876335
[TBL] [Abstract][Full Text] [Related]
10. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
11. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2.
Poon RY; Yamashita K; Adamczewski JP; Hunt T; Shuttleworth J
EMBO J; 1993 Aug; 12(8):3123-32. PubMed ID: 8393783
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells.
Buchkovich KJ; Ziff EB
Mol Biol Cell; 1994 Nov; 5(11):1225-41. PubMed ID: 7865886
[TBL] [Abstract][Full Text] [Related]
13. Cyclin A recruits p33cdk2 to the cellular transcription factor DRTF1.
Bandara LR; Adamczewski JP; Zamanian M; Poon RY; Hunt T; Thangue NB
J Cell Sci Suppl; 1992; 16():77-85. PubMed ID: 1297652
[TBL] [Abstract][Full Text] [Related]
14. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
Musgrove EA; Hamilton JA; Lee CS; Sweeney KJ; Watts CK; Sutherland RL
Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.
Firpo EJ; Koff A; Solomon MJ; Roberts JM
Mol Cell Biol; 1994 Jul; 14(7):4889-901. PubMed ID: 7516474
[TBL] [Abstract][Full Text] [Related]
16. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.
Devoto SH; Mudryj M; Pines J; Hunter T; Nevins JR
Cell; 1992 Jan; 68(1):167-76. PubMed ID: 1310073
[TBL] [Abstract][Full Text] [Related]
17. Association of human cyclin E with a periodic G1-S phase protein kinase.
Dulić V; Lees E; Reed SI
Science; 1992 Sep; 257(5078):1958-61. PubMed ID: 1329201
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts.
Hamada K; Takuwa N; Zhou W; Kumada M; Takuwa Y
Biochim Biophys Acta; 1996 Jan; 1310(1):149-56. PubMed ID: 9244189
[TBL] [Abstract][Full Text] [Related]
20. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs.
Rhodes N; Innes CL; Propst F; Paules RS
Oncogene; 1997 Jun; 14(25):3017-27. PubMed ID: 9223665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
